Bi Asset Management Fondsmaeglerselskab A Denali Therapeutics Inc. Call Options Transaction History
Bi Asset Management Fondsmaeglerselskab A
- $8.88 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DNLI
# of Institutions
237Shares Held
127MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$187 Million0.01% of portfolio
-
Baillie Gifford & CO12MShares$170 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$168 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$162 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.77MShares$96.3 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.91B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...